Allergan Inc. and Covidien Ltd Enter into Co-Promotion Agreement for LAP-BAND(R) Adjustable Gastric Banding System

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today announced that it has entered into an agreement with a subsidiary of Covidien Ltd. (NYSE: COV, BSX: COV), a leading global provider of healthcare products, under which Covidien will co-promote Allergan’s LAP-BAND® Adjustable Gastric Banding System to bariatric and other surgeons in the United States.

MORE ON THIS TOPIC